Kestra Medical Technologies Revenue 2025-2025 | KMTS
Kestra Medical Technologies revenue from 2025 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Kestra Medical Technologies Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $60 |
| 2024 | $28 |
|
Kestra Medical Technologies Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-07-31 | $19 |
| 2025-04-30 | $17 |
| 2025-01-31 | |
| 2024-07-31 | $13 |
| 2024-04-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.378B | $0.060B |
| Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. Kestra Medical Technologies, Ltd. is based in KIRKLAND, Wash. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.002B | 25.82 |
| EssilorLuxottica (ESLOY) | France | $171.957B | 0.00 |
| Boston Scientific (BSX) | United States | $154.367B | 35.30 |
| Stryker (SYK) | United States | $140.480B | 27.89 |
| Medtronic (MDT) | Ireland | $122.894B | 17.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.851B | 0.00 |
| Agilent Technologies (A) | United States | $42.956B | 27.80 |
| ResMed (RMD) | United States | $36.903B | 25.54 |
| GE HealthCare Technologies (GEHC) | United States | $34.155B | 16.34 |
| Koninklijke Philips (PHG) | Netherlands | $28.291B | 18.48 |
| Insulet (PODD) | United States | $23.696B | 73.55 |
| Terumo (TRUMY) | Japan | $22.712B | 25.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.842B | 11.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.285B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.828B | 31.74 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.614B | 11.01 |
| ICU Medical (ICUI) | United States | $3.435B | 21.81 |
| Haemonetics (HAE) | United States | $3.423B | 15.23 |
| Envista Holdings (NVST) | United States | $3.308B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.910B | 13.27 |
| LeMaitre Vascular (LMAT) | United States | $2.041B | 41.08 |
| Perrigo (PRGO) | Ireland | $1.949B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.869B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.644B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.535B | 9.86 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| Neogen (NEOG) | United States | $1.406B | 26.96 |
| Tilray Brands (TLRY) | Canada | $1.381B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.261B | 18.27 |
| BioLife Solutions (BLFS) | United States | $1.248B | 370.29 |
| InMode (INMD) | Israel | $0.923B | 10.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.790B | 0.00 |
| Surmodics (SRDX) | United States | $0.591B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.513B | 17.64 |
| CeriBell (CBLL) | United States | $0.477B | 0.00 |
| Evolus (EOLS) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.470B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.413B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.300B | 52.60 |
| Sanuwave Health (SNWV) | United States | $0.286B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.285B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.268B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 151.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.85 |
| Quanterix (QTRX) | United States | $0.244B | 0.00 |
| Owens & Minor (OMI) | United States | $0.227B | 2.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.88 |
| FitLife Brands (FTLF) | United States | $0.178B | 21.93 |
| OraSure Technologies (OSUR) | United States | $0.177B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Biote (BTMD) | United States | $0.131B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Sharps Technology (STSS) | United States | $0.104B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.38 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.26 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Zynex (ZYXI) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Bonk (BNKK) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.28 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |